Research article · 26 Aug 2023
EditorialPublished 22 Jul 2020
Exploration Uncovers Instrument Basic Parkinson's Dyskinesia
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Numerous individuals with Parkinson's sickness in the long run create incapacitating developments called dyskinesia, a symptom of their truly necessary dopamine substitution prescription. The system basic this undesirable symptom has been obscure, up to this point. A universal coordinated effort drove by Scripps Research, Florida has discovered a key reason, and with it, possibly, another course to giving alleviation. Dopamine substitution treatment improves Parkinson's side effects much from the start, however inevitably treatment offers approach to wild, jerky body developments. In any case, why? New exploration shows that fundamental this advancement is the treatment's unintended increase in a protein with the cumbersome name Rasguanine nucleotide-discharging factor 1, or RasGRP1 for short. This lift in RasGRP1 produces a course of impacts which lead to unusual, automatic developments known as LID, or L-DOPA-incited dyskinesia, says co-lead creator Srinivasa Subramaniam, Ph.D., partner educator of neuroscience at Scripps Research, Florida.
Keywords
Subjects
ChemistryPharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Short communication · 3 Aug 2021
Research Progress in Pathophysiological Mechanism of Dyskinesia in Parkinson's Disease
Conference abstract · 25 Sep 2017
Novel pharmaceutical interventions to relieve L-DOPA induced dyskinesia in Parkinson’s disease
Conference abstract · 5 Dec 2016
Clinical Trials using MRI Guided Focused Ultrasound ( ExAblate Transcranial System) for the management of Medically-Refractory Dyskinesia Symptoms of advanced Idiopathic Parkinson’s Disease and in patients with Benign Essential Tremorsrs
Review article · 16 Dec 2021
COMMUNICATION FEATURES AND EMOTIONAL STATE OF PATIENTS WITH PARKINSON’S DISEASE
More from this journal
The newest in Medicinal Chemistry.
Brief report · 30 Jun 2026
Covalent Drugs in Medicinal Chemistry: Emerging Opportunities and Ongoing Challenges
Commentary · 29 Dec 2025
Accelerating Drug Discovery: Molecular Docking and Virtual Screening
Opinion · 29 Dec 2025
Pharmacophore Modeling: A Cornerstone of Drug Discovery
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalMedicinal Chemistry
- SubjectChemistry
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Uttam Sowmya”

